# Insight Rx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insight-rx

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.insight-rx.com/
- Total disclosed funding: $10M
- Latest round: Series A (Sep 19, 2019)
- Investors on record: 6

## About

Founded in 2015 and based in California, US, Insight Rx, Inc. operates as a provider of a cloud-based platform powered by qualitative pharmacology and machine learning that helps healthcare providers to provide personalized treatments. Sirj Goswami (CEO), Ron Keizer (CSO), and Ranvir Mangat (COO) are the co-founders of the company. In February 2024, Insight Rx, Inc. raised growth funding from CIBC Innovation Banking.

The company specializes in model-informed precision dosing to enhance patient care. The firm provides advanced tools for individualizing drug dosing based on patients' unique pharmacological profiles. Insight Rx’s services include real-time clinical analytics and dosing decision support for both healthcare providers and biopharma companies. The company’s solutions, such as InsightRX Nova and InsightRX Apollo, support personalized dosing strategies from clinical development through to patient care.

The organization plans to use the February 2024 funding to further boost its growth.

## Funding rounds

- Series A, Sep 19, 2019, $10M — GreatPoint Ventures, Rock Health, HealthX Ventures, OSF Ventures, Leawood Venture Capital, Premier, Inc.

## Investors

- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series A
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Series A
- HealthX Ventures (https://capitalatlas.ai/funds/healthx-ventures) — Series A
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series A
- Leawood Venture Capital (https://capitalatlas.ai/funds/leawood-venture-capital) — Series A
- Premier, Inc. — Series A